CN1056516C - Traditional Chinese medicine preparation for treating cataract, glaucoma and optic nerve wither - Google Patents
Traditional Chinese medicine preparation for treating cataract, glaucoma and optic nerve wither Download PDFInfo
- Publication number
- CN1056516C CN1056516C CN94104944A CN94104944A CN1056516C CN 1056516 C CN1056516 C CN 1056516C CN 94104944 A CN94104944 A CN 94104944A CN 94104944 A CN94104944 A CN 94104944A CN 1056516 C CN1056516 C CN 1056516C
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- treatment
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese medicinal preparation for treating eye diseases. The present invention is a medicinal powder, or a honeyed pill or a capsule prepared from the traditional Chinese medicines: raw concha hallotidis, rehmannia roots, prepared rhizome of rehmannia, common yan rhizomes, tuckahoe, cortex moutan radices, oriental waterplantain rhizomes, schisandra fruits, black sesames, mulberry fruits, barbary wolfberry fruits, licorice roots, bupleurum roots and radix paeoniae alba. The present invention is mainly used for treating senile cataract and glaucoma burst with little vision and optic atrophy. The course of treatment is 1 to 2 months, the effective rate is more than 90%, and the cure rate is more than 65%. The present invention has the characteristics of convenient administration, reliable quality, short course of treatment, high curative effect, etc.
Description
The present invention relates to a kind of Chinese medicine preparation for the treatment of cataract, glaucoma, optic atrophy ophthalmic.
Eyes are one of vitals of human body, in case generation ophthalmic, all bring many miseries to the patient, especially cataract, glaucoma, optic atrophy are the high ophthalmics of sickness rate, not only bring from vision and be attenuated to blind misery to the patient, and treat this type of disease, still there is not specific drug at present.As to cataract, employing is taken medicine for a long time usually, the development of disease controlling, and the medicine that has is taken too much, also has certain side effect.When uncontrollable, then treat with operation method.The tcm therapy that has, as take the magnetic bead ball, need take half a year to one year (" rural area doctor's handbook is P.474<1969 〉); Take Radix Stephaniae Tetrandrae noctilucence ball, need take 1-2, the phase of taking is long, and its curative effect is all undesirable.To glaucoma, optic atrophy, the effective curable substance of Shang Weijian.
Purpose of the present invention for the misery of removing the patient with carry forward Chinese medical marrow, is researched and developed out a kind of can conveniently taking, and need not operation, can treat the Chinese medicine preparation of cataract, glaucoma, optic atrophy.
On the basis of medicine ancient prescription group agent, filter out fruitful successive dynasties famous expert secret recipe under study for action, in conjunction with present-day medical knowledge with face the medical experience of art, the Chinese prescription that being mainly used in ophthalmics such as treatment cataract has been succeeded in developing in experiment repeatedly.Therefore the contained Chinese prescription composition of Chinese medicine preparation (weight) of treatment cataract of the present invention, glaucoma, optic atrophy is:
Concha Haliotidis 10-30 part Radix Rehmanniae 5-15 part
Radix Rehmanniae Preparata 5-15 part Rhizoma Dioscoreae 5-20 part
Poria 10-20 part Cortex Moutan 10-20 part
Rhizoma Alismatis 10-20 part Fructus Schisandrae Chinensis 3-18 part
Semen Sesami Nigrum 5-15 part Fructus Mori 10-20 part
Fructus Lycii 10-20 part Radix Glycyrrhizae 3-12 part
The powder of Radix Bupleuri 10-20 part Radix Paeoniae Alba 10-20 part.
Its making step is the fine powder that each flavor Chinese medicine powder is broken into 80-100 order (homemade sieve mesh), press the preparation of prescription content and mix, through pulverizing mix homogeneously for the second time, sieve and get the thin medicated powder of 100-120 purpose again, carry out packing by the 30g/ bag, promptly make the cataractous powder medicine of treatment of the present invention.Described operating process must be carried out under aseptic condition.Also powder medicated powder can be added adjuvant and make the capsule of conveniently taking; Can also add Mel and make honeyed pill.
The best composition (weight) of the contained Chinese prescription of Chinese medicine preparation of treatment ophthalmic of the present invention is: 24 parts of Concha Haliotidis, 10 parts in the Radix Rehmanniae, 10 parts in Radix Rehmanniae Preparata, 10 parts of Rhizoma Dioscoreaes, 15 parts in Poria, 15 parts of Cortex Moutans, 15 parts of Rhizoma Alismatis, 6 parts of Fructus Schisandrae Chinensis, 10 parts of Semen Sesami Nigrums, 15 parts of Fructus Mori, 15 parts of Fructus Lycii, 6 parts in Radix Glycyrrhizae, 15 parts of Radix Bupleuri, 15 parts of the Radix Paeoniae Albas.
Instructions of taking with Chinese medicine preparation of the present invention is with powder medicine, brews with 100 ℃ of boiled water and takes after 8-10 minute, can also decoct a drug wrapped better effects if.Its dose is to obey every day three times, each 30g.Generally take medicine and can receive produce effects in 10-20 days, continuous use is about 2 months, and vision can be recovered as ordinary person.Show through clinic trial: still have cataract, optic atrophy, the glaucoma of light sensation that significant effect is arranged with Chinese medicine preparation treatment of the present invention.As be used for the treatment of senile, the cataract patient that sets out in the 1200 routine left and right sides, and effective percentage is more than 90%, and cure rate reaches more than 65%; Optic atrophy 1000 examples, effective percentage can reach 95%, and cure rate is more than 60%; Glaucoma 800 routine effective percentage 90%, cure rate is more than 70%.
Example 1
Take by weighing Concha Haliotidis 12Kg, Radix Rehmanniae 6Kg, Radix Rehmanniae Preparata 6Kg, Rhizoma Dioscoreae 6Kg, Poria 6Kg, Cortex Moutan 6Kg, Rhizoma Alismatis 8Kg, Fructus Schisandrae Chinensis 4Kg, Semen Sesami Nigrum 6Kg, Fructus Mori 6Kg, Fructus Lycii 4Kg, Radix Glycyrrhizae 3Kg, Radix Bupleuri 6Kg, Radix Paeoniae Alba 6Kg pulverize with pulverizer respectively, excessively behind 80 mesh sieves, mixing mixes again and pulverizes, and crosses 100 mesh sieves.Make medicated powder powder.Wrap in aseptic, sanitary condition by 30g/ and carry out packing, promptly make the powder Chinese medicine preparation that clinically to take.
Example 2
Producing powdery powder prescription by example 1 method step is: Concha Haliotidis 24Kg, Radix Rehmanniae 10Kg, Radix Rehmanniae Preparata 10Kg, Rhizoma Dioscoreae 10Kg, Poria 15Kg, Cortex Moutan 15Kg, Rhizoma Alismatis 15Kg, Fructus Schisandrae Chinensis 6Kg, Semen Sesami Nigrum 10Kg, Fructus Mori 15Kg, Fructus Lycii 15Kg, Radix Glycyrrhizae 6Kg, Radix Bupleuri 15Kg, Radix Paeoniae Alba 15Kg.
Claims (4)
1. Chinese medicine preparation for the treatment of ophthalmic is characterized in that it is mainly made by following parts by weight raw material of Chinese medicine:
Concha Haliotidis 10-30 part Radix Rehmanniae 5-15 part
Radix Rehmanniae Preparata 5-15 part Rhizoma Dioscoreae 5-20 part
Poria 10-20 part Cortex Moutan 10-20 part
Rhizoma Alismatis 10-20 part Fructus Schisandrae Chinensis 3-18 part
Semen Sesami Nigrum 5-15 part Fructus Mori 10-20 part
Fructus Lycii 10-20 part Radix Glycyrrhizae 3-12 part
Radix Bupleuri 10-20 part Radix Paeoniae Alba 10-20 part
2. the Chinese medicine preparation of treatment ophthalmic as claimed in claim 1 is characterized in that it is to add the honeyed pill that Mel is made in described raw material of Chinese medicine.
3. the Chinese medicine preparation of treatment ophthalmic as claimed in claim 1 is characterized in that it is to add the capsule that the capsule adjuvant is made in described raw material of Chinese medicine.
4. the Chinese medicine preparation of treatment ophthalmic as claimed in claim 1 is characterized in that the raw material of described preparation consists of:
10 parts in 24 parts of Radix Rehmanniae of Concha Haliotidis
10 parts of 10 portions of Rhizoma Dioscoreaes of Radix Rehmanniae Preparata
15 parts of 15 parts of Cortex Moutans of Poria
6 parts of 15 parts of Fructus Schisandrae Chinensis of Rhizoma Alismatis
15 parts of 10 parts of Fructus Mori of Semen Sesami Nigrum
6 parts in 15 portions of Radix Glycyrrhizaes of Fructus Lycii
15 parts of 15 portions of Radix Paeoniae Albas of Radix Bupleuri
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94104944A CN1056516C (en) | 1994-05-10 | 1994-05-10 | Traditional Chinese medicine preparation for treating cataract, glaucoma and optic nerve wither |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94104944A CN1056516C (en) | 1994-05-10 | 1994-05-10 | Traditional Chinese medicine preparation for treating cataract, glaucoma and optic nerve wither |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1119944A CN1119944A (en) | 1996-04-10 |
CN1056516C true CN1056516C (en) | 2000-09-20 |
Family
ID=5031820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN94104944A Expired - Fee Related CN1056516C (en) | 1994-05-10 | 1994-05-10 | Traditional Chinese medicine preparation for treating cataract, glaucoma and optic nerve wither |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1056516C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100411660C (en) * | 2006-03-09 | 2008-08-20 | 北京市眼科研究所 | Chinese medicine composition for treating optic atrophy and preparing method therefor |
CN104707006A (en) * | 2015-03-03 | 2015-06-17 | 李军 | Radioactive preparation capable of promoting blood circulation and dredging meridians for cataract patients and preparation thereof |
-
1994
- 1994-05-10 CN CN94104944A patent/CN1056516C/en not_active Expired - Fee Related
Non-Patent Citations (4)
Title |
---|
《中医药信息》1987年第2期 1987.1.1 王尚明,羊肝丸治疗73例视神经萎缩临床疗效观察 * |
《辽宁中医杂志》1986年第10卷第10期 1986.1.1 曾媛,化障汤治疗初中期老年性白内障105例 * |
《辽宁中医杂志》1986年第10卷第10期 1986.1.1 曾媛,化障汤治疗初中期老年性白内障105例;《陕西中医》1991年第12卷第11期 1991.1.1 滕维城等,复明片治疗青光眼150例;《中医药信息》1987年第2期 1987.1.1 王尚明,羊肝丸治疗73例视神经萎缩临床疗效观察 * |
《陕西中医》1991年第12卷第11期 1991.1.1 滕维城等,复明片治疗青光眼150例 * |
Also Published As
Publication number | Publication date |
---|---|
CN1119944A (en) | 1996-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101607022B (en) | Chinese medicament bone-knitting pellet preparation | |
CN1318058C (en) | Method for preparing concentrated pill for treating mammary gland proliferation disease | |
CN1056516C (en) | Traditional Chinese medicine preparation for treating cataract, glaucoma and optic nerve wither | |
CN103285329B (en) | Medicament for treating women dysmenorrhea and preparation method thereof | |
CN108653429A (en) | A kind of Chinese medicine composition that treating sty disease and its application | |
CN1634213A (en) | Chinese medicinal formulation for hematogenesis | |
CN1218708C (en) | Chinese medicine prescription for curing eye disease and its preparation method | |
CN102370925A (en) | Chinese herbal medicine preparation for treating hypomnesis and preparation method thereof | |
CN110478442A (en) | A kind of Multifunctional eye drops and preparation method thereof | |
CN1418701A (en) | Bushenshansong drink and preparation method thereof | |
CN114848724B (en) | Traditional Chinese medicine composition for treating migraine and preparation method thereof | |
CN1132095A (en) | Nurishing tonic for building body | |
CN100415270C (en) | Diabetes treating medicine | |
CN103341014A (en) | Drug for invigorating kidney and enhancing sexual function, and preparation method thereof | |
CN1123355C (en) | Process for preparing Chinese medicine preparation of treating pyelonephritis | |
CN103285128A (en) | Traditional Chinese medicine for treating bronchial asthma and preparation method thereof | |
CN102580023A (en) | Medicament for treating disorder of spleen and stomach and abdominal swelling and pain | |
CN112076276B (en) | Pharmaceutical composition for treating allergic rhinitis and preparation method thereof | |
CN102908508B (en) | Medicinal composition for treating seborrheic alopecia and preparation method thereof | |
CN106692786A (en) | Traditional Chinese medicine formula of acne treatment capsule | |
CN1048885C (en) | Xinpishenxiao prescription and preparation thereof | |
CN1256958C (en) | Miao nationality medicine for treating enuresis and its compounding method | |
CN106491730A (en) | A kind of treat Chinese medicine composition of glaucoma and preparation method thereof | |
CN118750562A (en) | Traditional Chinese medicine granule for treating senile cataract | |
CN104474200A (en) | Orally taken traditional Chinese medicinal liquid for treating Adie syndrome and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |